Microbot Medical Inc (NASDAQ:MBOT) does about 2.42M shares in volume on a normal day but saw 1173064 shares change hands in the recent trading day. The company now has a market cap of 99.31M USD. Its current market price is $2.73, marking an increase of 2.25% compared to the previous close of $2.67. The 52 week high reached by this stock is $3.38 whilst the lowest price level in 52 weeks is $0.82.
The consensus objective for the share price is $9.00, suggesting that the stock has a potential upside of 69.67% over the period.
FactSet Research has provided data showing that 1 brokerages have issued ratings for the stock. 0 analysts have rated it as a sell, while 0 advise that it is a overweight. 1 analysts have rated it as a buy and 0 have advised that investors hold their positions. The consensus recommendation rating is Buy and Wall Street’s advice is for investors to Strong Buy the stock.
The company shares received a number of brokerage firm price updates over the past month, with the latest being on January 13, 2020 when H.C. Wainwright reiterated the stock to “Buy” and issued a price target of between $12 and $26. Ladenburg Thalmann initiated its price target at $1.75.
The current price level is 4.90%, 21.50%, and 81.07% away from its SMA20, SMA50, and SMA200 respectively, with the MBOT price moving below the 50-day SMA on current market day. Microbot Medical Inc (MBOT) stock is up 1.11% over the week and 14.23% over the past month. Its price is 143.75% year-to-date and 173.00% over the past year.
To reach the target analysts have set, the stock logically needs to grow 69.67 percent from here.
Outstanding shares total 36.38M with insiders holding 0.67% of the shares and institutional holders owning 6.52% of the company’s common stock. The company has a return on investment of -40.25% and return on equity of -66.48%. The beta has a value of 1.14. Price to book ratio is 3.28.
